Skip to main content
Log in

The role and strategy of ISoP in global pharmacovigilance

  • Commentary
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Applying the WHO definition of pharmacovigilance, the International Society of Pharmacovigilance, (ISoP) is concerned with all aspects of medicine safety. The safety of patients exposed to medicines depends on a wide variety of factors, where the understanding of each factor is associated with its own professional competence and skillset. For pharmacovigilance systems to work efficiently, a broad understanding of the necessary contribution of each of the different scientific competence areas and professional skills is required. ISoP is an independent, not-for-profit international professional organization, concerned with the best interest of patients exposed to pharmaceutical interventions in all healthcare systems in the world. ISoP offers an open platform for professionals from around the world with different expertise and skillsets, to network and exchange information and knowledge in a friendly environment. The society wishes to become a stronger global voice, speaking up in favour of patient safety and to be at the frontline of the global patient safety movement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, et al. Adverse drug reaction monitoring: doing it the french way. Lancet. 1985;2(8463):1056–8.

    Article  CAS  Google Scholar 

  2. Anonymous. The importance of Pharmacovigilance. Safety monitoring of medicinal products WHO 2002 http://apps.who.int/iris/bitstream/10665/42493/1/a75646.pdf. Accessed 11 Jan 2018.

  3. www.isoponline.org. Accessed 11 Jan 2018.

  4. Velo G. Ecopharmacovigilance. In: Edwards IR, Lindquist M, editors. Pharmacovigilance, critique and ways forward. Berlin: Springer; 2017. p. 195–205.

    Chapter  Google Scholar 

  5. Olsson S, Wong ICK, Delumeau J-C, Harrison-Woolrych M. The new phase of ISoP. Drug Saf. 2017;40:841–4.

    Article  Google Scholar 

  6. The International Society of Pharmacovigilance 18th Annual Meeting. http://www.isop2018geneva.org/. Accessed 18 July 2018.

  7. McCarthy D, Bahri P, Barnres J, Delumeau J-C, Edwards B, Harrison-Woolrych M. An update on ISoP special interest groups (SIGs). Drug Saf. 2018;41:1–6.

    Article  Google Scholar 

  8. Bahri P, Dodoo AN, Edwards BD, Edwards IR, Fermont I, Hagemann U, Hartigan-Go K, Hugman B, Mol PG. The ISoP CommSIG for improving medicinal product risk communication: a new special interest group of the International Society of Pharmacovigilance. Drug Saf. 2015;38:621–7 (on behalf of the ISoP CommSIG).

    Article  Google Scholar 

  9. Anonymous. WHO pharmaceuticals newsletter no 6, 2017, p. 22 http://www.who.int/medicines/publications/PharmaNewsletter6_17/en/. Accessed 11 Jan 2018.

  10. Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, et al. Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug Saf. 2014;37:743–59.

    Article  Google Scholar 

  11. Springer-Nature. Drug safety journal. https://www.springer.com/adis/journal/40264. Accessed 18 July 2018.

Download references

Funding

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sten Olsson.

Ethics declarations

Conflicts of interest

The authors declared that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Olsson, S., Harrison-Woolrych, M. The role and strategy of ISoP in global pharmacovigilance. Int J Clin Pharm 40, 740–743 (2018). https://doi.org/10.1007/s11096-018-0708-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-018-0708-7

Keywords

Navigation